Who Paid My Doc
Srinivas Murali
Advanced Heart Failure and Transplant Cardiology Pittsburgh, PA Medical Doctor
NPI 1316921877 CMS profile 196023
320 E North Ave, Pittsburgh, PA 15212
General payments
$39,488
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$125,580
Through program year 2024, Srinivas Murali of Pittsburgh, PA is reported in the CMS Open Payments database as having received $39,488 across 82 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $125,580 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 77th percentile of Advanced Heart Failure and Transplant Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
6 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $14 | 1 | |
| 2023 | General | $6,215 | 12 | |
| 2022 | General | $8,636 | 25 | |
| 2021 | General | $4,846 | 10 | |
| 2020 | General | $7,216 | 6 | |
| 2019 | General | $12,560 | 28 |
Beside peers
- Srinivas Murali
- Advanced Heart Failure and Transplant Cardiology median
- Middle half of Advanced Heart Failure and Transplant Cardiology
- National median
In program year 2025, general payments to Srinivas Murali were reported at $0. Among 967 Advanced Heart Failure and Transplant Cardiology profiles paid that year, the median was $1,024 and the middle half received between $289 and $6,890.
Show as a table
| Year | Srinivas Murali | Advanced Heart Failure and Transplant Cardiology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $12,560 | $863 | $224–$4,562 | $163 |
| 2020 | $7,216 | $452 | $122–$3,992 | $114 |
| 2021 | $4,846 | $550 | $159–$3,571 | $132 |
| 2022 | $8,636 | $729 | $221–$4,357 | $149 |
| 2023 | $6,215 | $1,002 | $309–$5,827 | $160 |
| 2024 | $14 | $931 | $273–$5,204 | $164 |
| 2025 | $0 | $1,024 | $289–$6,890 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 1 drugPart D claims
12
Drug cost
$12,514
Branded share of claims
100%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | Brand | 12 | $12,514 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 104,182 Part D prescribers listed as Internal Medicine; they describe a distribution and say nothing about conduct.
Records
82 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Advanced Heart Failure and Transplant Cardiology in Pennsylvania
Anjali Vaidya
Advanced Heart Failure and Transplant Cardiology · Philadelphia, PA
Brendan Carry
Advanced Heart Failure and Transplant Cardiology · Danville, PA
Andrew Pogozelski
Advanced Heart Failure and Transplant Cardiology · Pittsburgh, PA
Jesus Rame
Advanced Heart Failure and Transplant Cardiology · Philadelphia, PA
Christoph Droogan
Advanced Heart Failure and Transplant Cardiology · Wynnewood, PA
Ileana Pina
Advanced Heart Failure and Transplant Cardiology · Philadelphia, PA
Related records
Advanced Heart Failure and Transplant Cardiology in Pennsylvania
Practitioners in the same specialty and state, ranked by reported value.
All Advanced Heart Failure and Transplant Cardiology
Everyone recorded under this specialty, nationwide.
Doctors in Pennsylvania
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.